Stocks and Investing
Stocks and Investing
Wed, September 13, 2023
[ 12:00 AM ] - WOPRAI
Tue, September 12, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Driscoll Reiterated (BDTX) at Buy and Held Target at $10 on, Sep 12th, 2023
Robert Driscoll of Wedbush, Reiterated "Black Diamond Therapeutics, Inc." (BDTX) at Buy and Held Target at $10 on, Sep 12th, 2023.
Robert has made no other calls on BDTX in the last 4 months.
There are 3 other peers that have a rating on BDTX. Out of the 3 peers that are also analyzing BDTX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robert
- Joseph Catanzaro of "Piper Sandler" Initiated at Buy and Held Target at $11 on, Friday, July 14th, 2023
- Bradley Canino of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Friday, June 30th, 2023
- Robert Burns of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Held Target at $11 on, Wednesday, June 28th, 2023
Contributing Sources